Form 4: Quest Diagnostics Director Timothy M. Ring Reports Changes in Beneficial Ownership

Director Timothy M. Ring reports acquisition of phantom stock units due to elective deferrals and dividend reinvestments in Quest Diagnostics Incorporated.

Summary

• Timothy M. Ring, a director of Quest Diagnostics Inc., filed a Form 4 to report changes in beneficial ownership.
• The report indicates the acquisition of 251 phantom stock units on April 1, 2025, resulting from elective deferrals of cash compensation under the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors.
• These phantom stock units become payable in cash upon the director's termination of service.
• The total number of phantom stock units accrued as of the transaction date is 16,409.562, including units credited from dividend reinvestment transactions.
• The reporting person directly owns these phantom stock units.

Sentiment

Score: 7

Explanation: The document is a standard regulatory filing, indicating normal business operations and executive compensation practices. There is nothing inherently positive or negative, but it reflects ongoing management participation in the company's equity.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common among publicly traded companies. It reflects standard practices for director compensation and deferred compensation plans.

Stakeholder Impact

• Shareholders may be interested in executive compensation details.
• The filing provides transparency regarding director's stake in the company.

Key Dates

Keywords

Form 4, Quest Diagnostics, Director, Beneficial Ownership, Phantom Stock Units, Deferred Compensation, Dividend Reinvestment, DGX